Connect your AI

SRTA SRTA Gain on sale of business and assets

Gain on sale of business and assets at other companies

Merit Medical SystemsMMSI

——

Other financials

Income statement

Revenue$67.4M+87.4%

Gross profit$14.1M+100%

Operating income-$3.0M+47.7%

Net income$2.2M+162%

EPS (diluted)$0.03+175%

Balance sheet

Cash & equivalents$59.0M+65.3%

Total debt$4.5M-50.7%

Total equity$285.7M+30.0%

Total assets$327.6M+30.8%

Cash flow

Operating cash flow$3.9M+1,679%

CapEx$5.2M+98.1%

Free cash flow-$1.3M+54.8%

Valuation

Market cap$463.78M+24.0%

Enterprise value$409.26M—

P/E8.9×—

P/S1.8×—

Profitability

Gross margin21.7%+1.3pp

Operating margin-7.8%-2.8pp

Net margin21%+13.6pp

FCF margin-22.4%+1,712pp

Returns & leverage

Return on equity15.6%+10.0pp

Debt / equity0×0.0×

Current ratio5.9×-1.0×

Where this comes from

Reported directly by SRTA in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSaleOfBusiness.

The official record: SRTA’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about SRTA's gain on sale of business and assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is SRTA's gain on sale of business and assets?: SRTA (SRTA) reported gain on sale of business and assets of -$344K in Q1 2026.